These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21206346)

  • 1. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrate use in diabetes: new concepts.
    Bloomgarden ZT; Drexler A
    J Diabetes; 2011 Mar; 3(1):1-2. PubMed ID: 21159144
    [No Abstract]   [Full Text] [Related]  

  • 3. [Part II. Combination statin plus fibrate regimens (free and fixed)].
    Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():11-9. PubMed ID: 27473466
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
    Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
    Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care.
    Rutter MK; Nesto RW
    Eur Heart J; 2011 Sep; 32(18):2247-55. PubMed ID: 21705358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol.
    Sathavarodom N; Boonyavarakul A
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S166-72. PubMed ID: 21280530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic vascular disease.
    Feingold KR; Siperstein MD
    Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
    [No Abstract]   [Full Text] [Related]  

  • 8. All at sea: new lipid-lowering drug trials continue to disappoint.
    Wierzbicki AS
    Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?
    Feher MD; Elkeles RS
    Heart; 1999 Jan; 81(1):10-1. PubMed ID: 10220537
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
    MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial risk in type 2 diabetes: from mega-trials to prescription].
    Bonnet F; Moulin P
    Rev Prat; 2003 May; 53(10):1095-101. PubMed ID: 12846030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
    Armitage J; Collins R
    Heart; 2000 Oct; 84(4):357-60. PubMed ID: 10995396
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent trials of lipid lowering.
    Ray KK; Cannon CP; Braunwald E
    Int J Clin Pract; 2007 Jul; 61(7):1145-59. PubMed ID: 17577297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cardiovascular disease utilizing fibrates--a pooled meta-analysis.
    Loomba RS; Arora R
    Am J Ther; 2010; 17(6):e182-8. PubMed ID: 20535009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrates in the light of large clinical trials].
    Krysiak R; Rudzki H; Handzlik-Orlik G; Gdula-Dymek A; Okopień B
    Pol Merkur Lekarski; 2015 Apr; 38(226):222-7. PubMed ID: 25938391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies for diabetic dyslipidaemia.
    Bell DS; Al Badarin F; O'Keefe JH
    Diabetes Obes Metab; 2011 Apr; 13(4):313-25. PubMed ID: 21205114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.